Cargando…

Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling

Under healthy conditions, pancreatic β-cells produce and secrete the insulin hormone in response to blood glucose levels. Under diabetic conditions, however, β-cells are compelled to continuously secrete larger amounts of insulin to reduce blood glucose levels, and thereby, the β-cell function is de...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneto, Hideaki, Obata, Atsushi, Kimura, Tomohiko, Shimoda, Masashi, Sanada, Junpei, Fushimi, Yoshiro, Katakami, Naoto, Matsuoka, Takaaki, Kaku, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763860/
https://www.ncbi.nlm.nih.gov/pubmed/33322512
http://dx.doi.org/10.3390/ijms21249444
_version_ 1783628118605430784
author Kaneto, Hideaki
Obata, Atsushi
Kimura, Tomohiko
Shimoda, Masashi
Sanada, Junpei
Fushimi, Yoshiro
Katakami, Naoto
Matsuoka, Takaaki
Kaku, Kohei
author_facet Kaneto, Hideaki
Obata, Atsushi
Kimura, Tomohiko
Shimoda, Masashi
Sanada, Junpei
Fushimi, Yoshiro
Katakami, Naoto
Matsuoka, Takaaki
Kaku, Kohei
author_sort Kaneto, Hideaki
collection PubMed
description Under healthy conditions, pancreatic β-cells produce and secrete the insulin hormone in response to blood glucose levels. Under diabetic conditions, however, β-cells are compelled to continuously secrete larger amounts of insulin to reduce blood glucose levels, and thereby, the β-cell function is debilitated in the long run. In the diabetic state, expression levels of insulin gene transcription factors and incretin receptors are downregulated, which we think is closely associated with β-cell failure. These data also suggest that it would be better to use incretin-based drugs at an early stage of diabetes when incretin receptor expression is preserved. Indeed, it was shown that incretin-based drugs exerted more protective effects on β-cells at an early stage. Furthermore, it was shown recently that endothelial cell dysfunction was also associated with pancreatic β-cell dysfunction. After ablation of insulin signaling in endothelial cells, the β-cell function and mass were substantially reduced, which was also accompanied by reduced expression of insulin gene transcription factors and incretin receptors in β-cells. On the other hand, it has been drawing much attention that incretin plays a protective role against the development of atherosclerosis. Many basic and clinical data have underscored the importance of incretin in arteries. Furthermore, it was shown recently that incretin receptor expression was downregulated in arteries under diabetic conditions, which likely diminishes the protective effects of incretin against atherosclerosis. Furthermore, a series of large-scale clinical trials (SPAED-A, SPIKE, LEADER, SUSTAIN-6, REWIND, PIONEER trials) have shown that various incretin-related drugs have beneficial effects against atherosclerosis and subsequent cardiovascular events. These data strengthen the hypothesis that incretin plays an important role in the arteries of humans, as well as rodents.
format Online
Article
Text
id pubmed-7763860
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77638602020-12-27 Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling Kaneto, Hideaki Obata, Atsushi Kimura, Tomohiko Shimoda, Masashi Sanada, Junpei Fushimi, Yoshiro Katakami, Naoto Matsuoka, Takaaki Kaku, Kohei Int J Mol Sci Review Under healthy conditions, pancreatic β-cells produce and secrete the insulin hormone in response to blood glucose levels. Under diabetic conditions, however, β-cells are compelled to continuously secrete larger amounts of insulin to reduce blood glucose levels, and thereby, the β-cell function is debilitated in the long run. In the diabetic state, expression levels of insulin gene transcription factors and incretin receptors are downregulated, which we think is closely associated with β-cell failure. These data also suggest that it would be better to use incretin-based drugs at an early stage of diabetes when incretin receptor expression is preserved. Indeed, it was shown that incretin-based drugs exerted more protective effects on β-cells at an early stage. Furthermore, it was shown recently that endothelial cell dysfunction was also associated with pancreatic β-cell dysfunction. After ablation of insulin signaling in endothelial cells, the β-cell function and mass were substantially reduced, which was also accompanied by reduced expression of insulin gene transcription factors and incretin receptors in β-cells. On the other hand, it has been drawing much attention that incretin plays a protective role against the development of atherosclerosis. Many basic and clinical data have underscored the importance of incretin in arteries. Furthermore, it was shown recently that incretin receptor expression was downregulated in arteries under diabetic conditions, which likely diminishes the protective effects of incretin against atherosclerosis. Furthermore, a series of large-scale clinical trials (SPAED-A, SPIKE, LEADER, SUSTAIN-6, REWIND, PIONEER trials) have shown that various incretin-related drugs have beneficial effects against atherosclerosis and subsequent cardiovascular events. These data strengthen the hypothesis that incretin plays an important role in the arteries of humans, as well as rodents. MDPI 2020-12-11 /pmc/articles/PMC7763860/ /pubmed/33322512 http://dx.doi.org/10.3390/ijms21249444 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kaneto, Hideaki
Obata, Atsushi
Kimura, Tomohiko
Shimoda, Masashi
Sanada, Junpei
Fushimi, Yoshiro
Katakami, Naoto
Matsuoka, Takaaki
Kaku, Kohei
Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling
title Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling
title_full Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling
title_fullStr Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling
title_full_unstemmed Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling
title_short Notable Underlying Mechanism for Pancreatic β-Cell Dysfunction and Atherosclerosis: Pleiotropic Roles of Incretin and Insulin Signaling
title_sort notable underlying mechanism for pancreatic β-cell dysfunction and atherosclerosis: pleiotropic roles of incretin and insulin signaling
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763860/
https://www.ncbi.nlm.nih.gov/pubmed/33322512
http://dx.doi.org/10.3390/ijms21249444
work_keys_str_mv AT kanetohideaki notableunderlyingmechanismforpancreaticbcelldysfunctionandatherosclerosispleiotropicrolesofincretinandinsulinsignaling
AT obataatsushi notableunderlyingmechanismforpancreaticbcelldysfunctionandatherosclerosispleiotropicrolesofincretinandinsulinsignaling
AT kimuratomohiko notableunderlyingmechanismforpancreaticbcelldysfunctionandatherosclerosispleiotropicrolesofincretinandinsulinsignaling
AT shimodamasashi notableunderlyingmechanismforpancreaticbcelldysfunctionandatherosclerosispleiotropicrolesofincretinandinsulinsignaling
AT sanadajunpei notableunderlyingmechanismforpancreaticbcelldysfunctionandatherosclerosispleiotropicrolesofincretinandinsulinsignaling
AT fushimiyoshiro notableunderlyingmechanismforpancreaticbcelldysfunctionandatherosclerosispleiotropicrolesofincretinandinsulinsignaling
AT katakaminaoto notableunderlyingmechanismforpancreaticbcelldysfunctionandatherosclerosispleiotropicrolesofincretinandinsulinsignaling
AT matsuokatakaaki notableunderlyingmechanismforpancreaticbcelldysfunctionandatherosclerosispleiotropicrolesofincretinandinsulinsignaling
AT kakukohei notableunderlyingmechanismforpancreaticbcelldysfunctionandatherosclerosispleiotropicrolesofincretinandinsulinsignaling